Intestinal Research

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care: Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews; Received January 4, 2022 Accepted March 23, 2022; DOI: https://doi.org/10.5217/ir.2022.00003 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis: Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis; Received January 10, 2022 Accepted March 16, 2022; DOI: https://doi.org/10.5217/ir.2022.00006 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis: Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park; Received November 25, 2021 Accepted March 16, 2022; DOI: https://doi.org/10.5217/ir.2021.00161 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies: Haruka Otake, Satohiro Matsumoto, Hirosato Mashima; Received October 9, 2021 Accepted January 26, 2022; DOI: https://doi.org/10.5217/ir.2021.00139 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests: José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset; Received September 23, 2021 Accepted December 25, 2021; DOI: https://doi.org/10.5217/ir.2021.00126 [Epub ahead of print]
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis: Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai; Received November 3, 2021 Accepted January 17, 2022; DOI: https://doi.org/10.5217/ir.2021.00154 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial: Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe; Received October 21, 2021 Accepted December 31, 2021; DOI: https://doi.org/10.5217/ir.2021.00143 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study: Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park; Received September 21, 2021 Accepted November 25, 2021; DOI: https://doi.org/10.5217/ir.2021.00125 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis: Jim O’Connell, Jayne Doherty, Amy Buckley, David Cormican, Cara Dunne, Karen Hartery, John Larkin, Finbar MacCarthy, Paul McCormick, Susan McKiernan, Brian Mehigan, Cian Muldoon, Ciara Ryan, Jacintha O’Sullivan, David Kevans; Received May 27, 2021 Accepted November 3, 2021; DOI: https://doi.org/10.5217/ir.2021.00073 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know: Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung, Clinical Practice Guideline Committee of the Korean Association for the Study of Intestinal Diseases; Received December 22, 2021 Accepted January 21, 2022; DOI: https://doi.org/10.5217/ir.2020.00172 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study: Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal; Received July 29, 2021 Accepted October 8, 2021; DOI: https://doi.org/10.5217/ir.2021.00106 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?: Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta; Received July 14, 2021 Accepted September 24, 2021; DOI: https://doi.org/10.5217/ir.2021.00099 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Landscape of inflammatory bowel disease in Singapore: Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi; Received June 28, 2021 Accepted August 23, 2021; DOI: https://doi.org/10.5217/ir.2021.00089 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements: Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung; Received August 8, 2021 Accepted September 9, 2021; DOI: https://doi.org/10.5217/ir.2021.00111 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Natural history of inflammatory bowel disease: a comparison between the East and the West: Eun Mi Song, Suk-Kyun Yang; Received July 28, 2021 Accepted September 20, 2021; DOI: https://doi.org/10.5217/ir.2021.00104 [Epub ahead of print]
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance: Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki; Received February 23, 2021 Accepted June 7, 2021; DOI: https://doi.org/10.5217/ir.2021.00032 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease: Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil H. Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, Bruno Pereira, David T. Rubin; Received February 5, 2021 Accepted May 30, 2021; DOI: https://doi.org/10.5217/ir.2021.00018 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study: Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Kim, Do Hyun Kim, Dennis Teng, Jong-Hwa Kim, Wonyong Kim, Chang Hwan Choi, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Received March 25, 2021 Accepted June 9, 2021; DOI: https://doi.org/10.5217/ir.2021.00049 [Epub ahead of print]
Cited By 2; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease: Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon; Received February 10, 2021 Accepted May 24, 2021; DOI: https://doi.org/10.5217/ir.2021.00022 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations: Dushyant Singh Dahiya, Asim Kichloo, Farah Wani, Jagmeet Singh, Dhanshree Solanki, Hafeez Shaka; Received March 17, 2021 Accepted May 5, 2021; DOI: https://doi.org/10.5217/ir.2021.00046 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease: Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, Masashi Ohno, Takayuki Imai, Kenichiro Takahashi, Yuji Naito, Junichi Iwamoto, Akira Honda, Naohiro Inohara, Akira Andoh; Received March 30, 2021 Accepted April 12, 2021; DOI: https://doi.org/10.5217/ir.2021.00054 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis: Shigenobu Emoto, Keisuke Hata, Hiroaki Nozawa, Kazushige Kawai, Toshiaki Tanaka, Takeshi Nishikawa, Yasutaka Shuno, Kazuhito Sasaki, Manabu Kaneko, Koji Murono, Yuuki Iida, Hiroaki Ishii, Yuichiro Yokoyama, Hiroyuki Anzai, Hirofumi Sonoda, Soichiro Ishihara; Received December 11, 2020 Accepted January 12, 2021; DOI: https://doi.org/10.5217/ir.2020.00158 [Epub ahead of print]
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Ahead-of Print